These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38455071)

  • 1. Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis.
    Gogoi M; Martin CA; Bird PW; Wiselka MJ; Gardener J; Ellis K; Renals V; Lewszuk AJ; Hargreaves S; Pareek M
    J Migr Health; 2024; 9():100217. PubMed ID: 38455071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
    Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
    Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune status of migrant populations in Europe and implications for vaccine-preventable disease control: a systematic review and meta-analysis.
    Cherri Z; Lau K; Nellums LB; Himmels J; Deal A; McGuire E; Mounier-Jack S; Norredam M; Crawshaw A; Carter J; Seedat F; Clemente NS; Bouaddi O; Friedland JS; Edelstein M; Hargreaves S
    J Travel Med; 2024 Aug; 31(6):. PubMed ID: 38423523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain.
    Norman FF; Comeche B; Martínez-Lacalzada M; Pérez-Molina JA; Gullón B; Monge-Maillo B; Chamorro S; López-Vélez R
    J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33611577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprotection to vaccine-preventable diseases among workers at a Victorian tertiary hospital.
    Andrew EC; Gibney KB; Denholm J; Leder K
    Aust N Z J Public Health; 2016 Jun; 40(3):284-9. PubMed ID: 27027875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review.
    Deal A; Halliday R; Crawshaw AF; Hayward SE; Burnard A; Rustage K; Carter J; Mehrotra A; Knights F; Campos-Matos I; Majeed A; Friedland JS; Edelstein M; Mounier-Jack S; Hargreaves S;
    Lancet Infect Dis; 2021 Dec; 21(12):e387-e398. PubMed ID: 34626552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
    PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving delivery and uptake of catch-up vaccination among adolescent and adult migrants in UK general practice: a mixed methods pilot study.
    Crawshaw AF; Goldsmith LP; Deal A; Carter J; Knights F; Seedat F; Lau K; Hayward SE; Yong J; Fyle D; Aspray N; Iwami M; Ciftci Y; Wurie F; Majeed A; Forster AS; Hargreaves S
    BMC Med; 2024 May; 22(1):186. PubMed ID: 38702767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
    Freidl GS; Tostmann A; Curvers M; Ruijs WLM; Smits G; Schepp R; Duizer E; Boland G; de Melker H; van der Klis FRM; Hautvast JLA; Veldhuijzen IK
    Vaccine; 2018 Mar; 36(12):1664-1672. PubMed ID: 29454516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprotection against Vaccine-Preventable Diseases amongst Health Care Workers in a Community Hospital, Qatar.
    Guanche Garcell H; Villanueva Arias A; Guilarte García E; Alfonso Serrano RN
    Int J Occup Environ Med; 2016 Oct; 7(4):234-40. PubMed ID: 27651085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.
    Taddei C; Ceccherini V; Niccolai G; Porchia BR; Boccalini S; Levi M; Tiscione E; Santini MG; Baretti S; Bonanni P; Bechini A
    Hum Vaccin Immunother; 2014; 10(9):2612-22. PubMed ID: 25483489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Maltezou HC; Karantoni H; Petrikkos P; Georgota P; Katerelos P; Liona A; Tsagarakis S; Theodoridou M; Hatzigeorgiou D
    Vaccine; 2020 Jan; 38(5):1181-1185. PubMed ID: 31761499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study.
    Staehelin C; Chernet A; Sydow V; Piso RJ; Suter-Riniker F; Funez S; Nickel B; Paris DH; Labhardt ND
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 31094415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study.
    Jablonka A; Happle C; Wetzke M; Dopfer C; Merkesdal S; Schmidt RE; Behrens GMN; Solbach P
    Infect Dis Ther; 2017 Dec; 6(4):487-496. PubMed ID: 28875465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019.
    von Linstow ML; Yde Nielsen A; Kirkby N; Eltvedt A; Nordmann Winther T; Bybeck Nielsen A; Bang D; Poulsen A
    Euro Surveill; 2021 Apr; 26(17):. PubMed ID: 33928900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.
    Crawshaw AF; Farah Y; Deal A; Rustage K; Hayward SE; Carter J; Knights F; Goldsmith LP; Campos-Matos I; Wurie F; Majeed A; Bedford H; Forster AS; Hargreaves S
    Lancet Infect Dis; 2022 Sep; 22(9):e254-e266. PubMed ID: 35429463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
    Charania NA; Gaze N; Kung JY; Brooks S
    Vaccine; 2019 May; 37(20):2661-2669. PubMed ID: 30967311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.
    Siberry GK; Patel K; Bellini WJ; Karalius B; Purswani MU; Burchett SK; Meyer WA; Sowers SB; Ellis A; Van Dyke RB; ;
    Clin Infect Dis; 2015 Sep; 61(6):988-95. PubMed ID: 26060291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.